Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment

Published:2019-05 Issue: Volume:133 Page:145-159
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Kulkarni Nishant S.,Parvathaneni Vineela,Shukla Snehal K.,Barasa Leonard,Perron Jeanette C.,Yoganathan Sabesan^ORCID,Muth Aaron,Gupta Vivek

Funder

St. John's University

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference59 articles.

1. Zinc oxide quantum dots: a potential candidate to detain liver cancer cells;Ahmad;Bioprocess Biosyst. Eng.,2015

2. Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy;Ali;Drug Des. Devel. Ther.,2019

3. Development of biosurfactant-based graphene quantum dot conjugate as a novel and fluorescent theranostic tool for cancer;Bansal;Int. J. Nanomedicine,2019

4. Differences in distribution of esterase between cell fractions of rat liver homogenates prepared in various media. Relevance to the lysosomal location of the enzyme in the intact cell;Barrow;Biochem. J.,1971

5. Cellular uptake of nanoparticles: journey inside the cell;Behzadi;Chem. Soc. Rev.,2017

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review;International Journal of Nanomedicine;2024-09

2. Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment;Beni-Suef University Journal of Basic and Applied Sciences;2024-07-26

3. Recent Development and Advancement in Quantum Dots in Pharmaceutical and Biomedical Fields for the Delivery of Drugs;Current Nanoscience;2024-07

4. Nanostructured ZnO‐CQD Hybrid Heterostructure Nanocomposites: Synergistic Engineering for Sustainable Design, Functional Properties, and High‐Performance Applications;ChemNanoMat;2024-06-18

5. REVITALIZING THERAPEUTICS: DRUG REPURPOSING AS A COST-EFFECTIVE STRATEGY FOR DRUG DEVELOPMENT;International Journal of Applied Pharmaceutics;2024-05-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3